Get 50% OFF This Summer!
Sudarshan Pharma Industries
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name 'Sudarshan Specialty Chemsolve Private Limited' on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from 'Sudarshan Specialty Chemsolve Private Limited' to 'Sudarshan Pharma Industries Private Limited' on 17 December 2016. Thereafter, the Company converted into a Public Limited pursuant to a special resolution passed by shareholders at the EGM held on December 12, 2016 and consequently, name of the Company was changed to 'Sudarshan Pharma Industries Limited' on January 5, 2017.
The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. Driven by passion for building an integrated chemical and pharmaceutical company, backed by their more than two decades of individual experience, the Promoters have been the pillars of the Company's growth since inception and have built a strong value system for the Company. With their enriching experience and progressive thinking, the company aims to continue to grow in the chemical and pharmaceutical industry in India and abroad.
The Company outsources its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, the company provides order and get them manufactured from various suppliers in India and abroad regularly. Specialty chemicals and Intermediates having wide application in pharma, paint, food and adhesive Industry. It is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It also offer services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing the innovative products as per their needs.
The Company carries about Ethical marketing of Pharmaceutical formulation & products in the Domestic and International market through distribution network and Sales force under its own brand. Presently, the Company has joined hands with regular suppliers having FDA and WHO approved plant along with their own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for their own brands.
Apart from these, the Company has launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and has established goodwill for quality products and have regular clients for the same. Further, it supplies generic pharmaceutical formulation as Make to order for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.
The Company operate both in domestic and international markets. Presently, it is supplying Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets. It has entered into MOU / Agreements with Storage Houses / Warehouses facility providers at Bhiwandi Thane, Maharashtra, Wada Palghar, Maharashtra and Baddi, Himachal Pradesh for using their premises for the stock keeping of the products. The Company has also entered into Lease Agreement with Group Company, Sudarshan Chempharm LLP for using its premises and land to set up proposed Manufacturing and Storage / Warehouse Facility at Wada, in Maharashtra.
In domestic pharmaceuticals markets, currently, the Company has good presence and is servicing through a Supply Chain Network of Consignee Agents with products range. It also provide onsite support & assistance to clients using their Drug Intermediates and Specialty Chemicals.
Sudarshan Pharma Industries share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Sudarshan Pharma Industries indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Sudarshan Pharma Industries is valued compared to its competitors.
Sudarshan Pharma Industries PE ratio helps investors understand what is the market value of each stock compared to Sudarshan Pharma Industries 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Sudarshan Pharma Industries evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Sudarshan Pharma Industries generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Sudarshan Pharma Industries in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Sudarshan Pharma Industries shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Sudarshan Pharma Industries compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Sudarshan Pharma Industries over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Sudarshan Pharma Industries helps investors get an insight into when they can enter or exit the stock. Key components of Sudarshan Pharma Industries Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Sudarshan Pharma Industries shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Sudarshan Pharma Industries ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Sudarshan Pharma Industries provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Sudarshan Pharma Industries highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Sudarshan Pharma Industries .
The balance sheet presents a snapshot of Sudarshan Pharma Industries ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App